MultiHance 用於 MRA 之相關文獻
Groarke JD, Waller AH, Vita TS, Michaud GF, Di Carli MF, Blankstein R, Kwong RY, Steigner M. Feasibility study of electrocardiographic and respiratory gated, gadolinium enhanced magnetic resonance angiography of pulmonary veins and the impact of heart rate and rhythm on study quality. J Cardiovasc Magn Reson. 2014 Jun 19;16:43
Faletti R, Rapellino A, Barisone F, Anselmino M, Ferraris F, Fonio P, Gaita F, Gandini G. Use of oral gadobenate dimeglumine to visualise the oesophagus during magnetic resonance angiography in patients with atrial fibrillation prior to catheter ablation. J Cardiovasc Magn Reson. 2014 Jun 13;16:41
www.ncbi.nlm.nih.gov/pubmed/24927953
Schneider G, Schürholz H, Kirchin MA, Bücker A, Fries P. Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol. 2013 Jan;43(2):202-11
www.ncbi.nlm.nih.gov/pubmed/23179483
Johansson L, Kirchin MA, Ahlström H. Gadobenate dimeglumine (MultiHance) in MR angiography: an in-vitro phantom comparison with gadopentetate dimeglumine (Magnevist) at different concentrations. Acta Radiol. 2012 Dec 1;53(10):1112-7
www.ncbi.nlm.nih.gov/pubmed/23081961
Li Y, Li X, Li D, Lu J, Xing X, Yan F, Li Y, Wang X, Iezzi R, De Cobelli F. Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study). AJNR Am J Neuroradiol. 2013 Apr;34(4):847-54.
www.ncbi.nlm.nih.gov/pubmed/23042922
Sandhu GS, Rezaee RP, Jesberger J, Wright K, Griswold MA, Gulani V. Time-resolved MR angiography of the legs at 3 T using a low dose of gadolinium: initial experience and contrast dynamics. AJR Am J Roentgenol. 2012 Mar;198(3):686-91.
www.ncbi.nlm.nih.gov/pubmed/22358010
Hodnett PA, Ward EV, Davarpanah AH, Scanlon TG, Collins JD, Glielmi CB, Bi X, Koktzoglou I, Gupta N, Carr JC, Edelman RR. Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA. AJR Am J Roentgenol. 2011 Dec;197(6):1466-73.
www.ncbi.nlm.nih.gov/pubmed/22109304
Neira C, Anzidei M, Napoli A, Kirchin MA, Cavallo Marincola B, Zaccagna F, Catalano C, Passariello R, Tedoldi F. Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries. Invest Radiol. 2011 Dec;46(12):774-82.
www.ncbi.nlm.nih.gov/pubmed/21730871
Mostardi PM, Haider CR, Glockner JF, Young PM, Riederer SJ. High spatial and temporal resolution imaging of the arterial vasculature of the lower extremity with contrast enhanced MR angiography. Clin Anat. 2011 May;24(4):478-88.
www.ncbi.nlm.nih.gov/pubmed/21509813
Woodard PK, Chenevert TL, Sostman HD, Jablonski KA, Stein PD, Goodman LR, Londy FJ, Narra V, Hales CA, Hull RD, Tapson VF, Weg JG. Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine. Int J Cardiovasc Imaging. 2012 Feb;28(2):295-301.
www.ncbi.nlm.nih.gov/pubmed/21337023
Iezzi R, Soulez G, Thurnher S, Schneider G, Kirchin MA, Shen N, Pirovano G, Spinazzi A. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium. Eur J Radiol. 2011 Feb;77(2):358-68.
www.ncbi.nlm.nih.gov/pubmed/19679417
Napoli A, Anzidei M, Marincola BC, Zaccagna F, Geiger D, Di Paolo PL, Zini C, Catalano C, Passariello R. Optimisation of a high-resolution whole-body MR angiography protocol with parallel imaging and biphasic administration of a single bolus of Gd-BOPTA: preliminary experience in the systemic evaluation of atherosclerotic burden in patients referred for endovascular procedures. Radiol Med. 2009 Jun;114(4):538-52
www.ncbi.nlm.nih.gov/pubmed/19430733
Anzalone N, Scotti R, Vezzulli P. High relaxivity contrast agents in MR angiography of the carotid arteries. Eur Radiol. 2006 Nov;16 Suppl 7:M27-34.
www.ncbi.nlm.nih.gov/pubmed/18655264
Douek PC. MultiHance in MRA of peripheral vasculature. Eur Radiol. 2005 Dec;15 Suppl 5:E17-23
www.ncbi.nlm.nih.gov/pubmed/18637227
Anzalone N, Scomazzoni F, Cirillo M, Righi C, Simionato F, Cadioli M, Iadanza A, Kirchin MA, Scotti G. Follow-up of coiled cerebral aneurysms at 3T: comparison of 3D time-of-flight MR angiography and contrast-enhanced MR angiography. AJNR Am J Neuroradiol. 2008 Sep;29(8):1530-6.
www.ncbi.nlm.nih.gov/pubmed/18556359
Rasmus M, Bremerich J, Egelhof T, Huegli RW, Bongartz G, Bilecen D. Total-body contrast-enhanced MRA on a short, wide-bore 1.5-T system: intra-individual comparison of Gd-BOPTA and Gd-DOTA. Eur Radiol. 2008 Oct;18(10):2265-73.
www.ncbi.nlm.nih.gov/pubmed/18431575
Attenberger UI, Michaely HJ, Wintersperger BJ, Sourbron SP, Lodemann KP, Reiser MF, Schoenberg SO. Three-dimensional contrast-enhanced magnetic-resonance angiography of the renal arteries: interindividual comparison of 0.2 mmol/kg gadobutrol at 1.5 T and 0.1 mmol/kg gadobenate dimeglumine at 3.0 T. Eur Radiol. 2008 Jun;18(6):1260-8.
www.ncbi.nlm.nih.gov/pubmed/18278504
Schneider G, Ballarati C, Grazioli L, Manfredi R, Thurnher S, Kroencke TJ, Taupitz M, Merlino B, Bonomo L, Shen N, Pirovano G, Kirchin MA, Spinazzi A. Gadobenate dimeglumine-enhanced MR angiography: Diagnostic performance of four doses for detection and grading of carotid, renal, and aorto-iliac stenoses compared to digital subtraction angiography. J Magn Reson Imaging. 2007 Oct;26(4):1020-32
www.ncbi.nlm.nih.gov/pubmed/17896354
Douek PC. MultiHance in MRA of peripheral vasculature. Eur Radiol. 2004 Jun;14 Suppl 7:O55-60
www.ncbi.nlm.nih.gov/pubmed/15503378
Goyen M, Debatin JF. Gadobenate dimeglumine (MultiHance) for magnetic resonance angiography: review of the literature. Eur Radiol. 2003 Nov;13 Suppl 3:N19-27.
www.ncbi.nlm.nih.gov/pubmed/15015877
Friese S, Klose U, Kastrup A, Krapf H, Küker W. [Enhanced MR-angiography (CE-MRA) of the supraaortic arteries: dose reduction with a contrast agent of high relaxivity (Gd-BOPTA)]. Rofo. 2003 Oct;175(10):1363-7. German.
www.ncbi.nlm.nih.gov/pubmed/14556105
Wikström J, Wasser MN, Pattynama PM, Bonomo L, Hamm B, Del Maschio A, Knopp MV, Marchal G, Barentsz JO, Oudkerk M, Hentrich HR, Daprà M, Kirchin MA, Shen N, Spinazzi A, Ahlström H. Gadobenate dimeglumine-enhanced magnetic resonance angiography of the pelvic arteries. Invest Radiol. 2003 Aug;38(8):504-15.
www.ncbi.nlm.nih.gov/pubmed/12874517